Newsfeed : Study: Herpes Therapy Does Not Reduce HIV Transmission Risk

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Newsfeed » January 2010

Most Popular Links
Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

15 Years Ago In POZ


More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to news@poz.com.


emailprint

January 22, 2010

Study: Herpes Therapy Does Not Reduce HIV Transmission Risk

Treating herpes simplex 2 (HSV-2) in HIV-positive people does not reduce the risk of transmitting HIV to their sexual partners, according to study from University of Washington at Seattle and reported by MedPage Today. Preliminary data were presented at the 15th Conference on Retroviruses and Opportunistic Infections in 2008.

This line of research is in response to epidemiological and laboratory observations that having HSV-2 increased the risk of contracting HIV. Researchers reasoned that the converse would be true: that HSV-2 treatment could reduce the risk of HIV transmission.

The large, randomized and placebo-controlled clinical trial involved 3,408 African couples in which one partner was HIV positive (but not on medication) and had HSV-2. Results showed that treating HSV-2 with acyclovir (Zovirax) significantly reduced HIV viral load but did not prevent transmission of the virus to the other partner. Study authors concluded that a greater reduction in viral load would be needed to prevent transmission in serodiscordant couples.

In the study, 84 HIV transmission cases between partners were verified. Of those, 41 took acyclovir, while the others were in the placebo group.

Also of note: Acyclovir reduced the occurrence of herpes lesions, proving that the HIV transmission cases in the study did not stem from nonadherence to the HSV-2 treatment.

Search: herpes, HSV-2, University of Washington, CROI, transmission, acyclovir


Scroll down to comment on this story.



Name:

(will display; 2-50 characters)

Email:

(will NOT display)

City:

(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules



Show comments (0 total)

 
[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar


    dambitious
    Gone
    New York


    Poz_Qt
    Columbus
    Ohio


    max38man
    Chicago
    Illinois


    jacob2608
    Panama City Beach
    Florida
Click here to join POZ Personals!
Ask POZ Pharmacist

Talk to Us
Poll
Are you a regular coffee drinker?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.